Clinical Trial Update: Genomic and Phenotypic Determinants of Resistance to Immunotherapies in Multiple Myeloma

View source ↗

Summary

A completed clinical trial (NCT03848676) investigates the genomic and phenotypic determinants of resistance to immunotherapies in patients with multiple myeloma…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Snippet

Sponsor: University of Turin, Italy | Conditions: Multiple Myeloma | Status: COMPLETED